Cureclip Pharmaceuticals Limited - Company Profile

It is a pharma public limited company based in Delhi, Delhi, India, established in 1990.

1990 Delhi, Delhi, India Active

Last Updated: January 06, 2026

About Cureclip Pharmaceuticals Limited

Cureclip Pharmaceuticals Limited, a active public limited company, was established on 22 November 1990 in Delhi, Delhi, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24230DL1990PLC042161. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹5.73 M.

It upholds a compliant status. Its leadership includes Vivek Goyal (Director), Rakhi (Director), Naresh Kumar Goyal (Director). Past directors included Vivek Goyal, Rakhi, Vinod Kumar. It holds ₹2.10 Cr open charges and ₹12.12 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Unit No. 1273, 12Th Floor, Aggarwal Cyber Plaza 2, Netaji Subash Place, Pitampura, Delhi, Delhi, 110034.

Company Details

CIN/LLPIN
U24230DL1990PLC042161
Registration Number
042161
Incorporation Date
22 November 1990
Authorized Capital
₹1.00 Cr
Paid-Up Capital
₹5.73 M
ROC Code
Roc Delhi
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 1.00 Cr as on 06-01-2026
Paid Up Capital ₹ 5.73 M as on 06-01-2026
Company Age 35 Year, 3 Months
Last Filing with ROC 31 Mar 2025
Open Charges ₹ 2.10 Cr as on 06-01-2026
Satisfied Charges ₹ 12.12 Cr as on 06-01-2026
Revenue Growth **** -8.85% (FY 2023)
Profit Growth **** -466.79% (FY 2023)
Ebitda **** 46.86% (FY 2023)
Net Worth -42.78% (FY 2023)
Total Assets -44.59% (FY 2023)

Comprehensive Company Insights

Explore comprehensive insights into Cureclip Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Cureclip Pharmaceuticals Limited?

Current Directors

Name	Designation	Appointment Date	Status
Vivek Goyal	Director	15 Dec 2016	Current
Rakhi	Director	26 Sep 2022	Current
Naresh Kumar Goyal	Director	01 Nov 2005	Current
Manoj Kumar Jha	Additional Director	01 Apr 2025	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Additional Director	30 Sep 2017	Past
Pramod Abcsdd	Additional Director	29 Sep 2023	Past
Pramod Abcsdd	Director	10 Jan 2022	Past
Pramod Abcsdd	Additional Director	29 Sep 2018	Past
Pramod Abcsdd	Director	14 Sep 2018	Past
Pramod Abcsdd	Director	15 Jul 2013	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Cureclip Pharmaceuticals.

Maiden Pharmaceuticals Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 8.85% decrease. The company also saw a substantial fall in profitability, with a 466.79% decrease in profit. The company's net worth observed a substantial decline by a decrease of 42.78%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

-8.85%

*******

Revenue from Operations

*******

-8.75%

*******

Total Assets

*******

-44.59%

*******

Profit or Loss

*******

-466.79%

*******

Net Worth

*******

-42.78%

*******

EBITDA

*******

46.86%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Cureclip Pharmaceuticals?

In 2023, Cureclip Pharmaceuticals had a promoter holding of 89.11% and a public holding of 10.89%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹21,000,000.00

Satisfied Charges

₹121,200,000.00

Charges Breakdown by Lending Institutions

Axis Bank Limited : 1.50 Cr
Others : 0.60 Cr

Latest Charge Details

Date	Lender	Amount	Status
18 Jan 2022	Axis Bank Limited	₹1.50 Cr	Open
26 Jul 2021	Others	₹6.00 M	Open
26 Feb 2022	Others	₹4.99 Cr	Satisfied
28 Aug 2002	Punjab & Sind Bank	₹4.60 Cr	Satisfied
28 Aug 2002	Punjab & Sind Bank	₹7.50 M	Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Cureclip Pharmaceuticals?

Unlock and access historical data on people associated with Cureclip Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Cureclip Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cureclip Pharmaceuticals's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Cureclip Pharmaceuticals

Recent Activity within the Organization

Annual General Meeting

The activity Cureclip Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.
30 Sep 2025
Director Appointment

The activity Manoj Kumar Jha was appointed as a Additional Director was appointed as a Additional Director on 01 Apr 2025 & has been associated with this company since 11 months 1 day . was completed.
01 Apr 2025
Balance Sheet

Cureclip Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was recorded as a recent event.
31 Mar 2025
Charges

A charge registered on 26 Feb 2022 via Charge ID 100548885 with Others was fully satisfied on 17 Feb 2023. was recorded as a recent event.
17 Feb 2023
Director Appointment

The activity Rakhi was appointed as a Director was appointed as a Director on 26 Sep 2022 & has been associated with this company since 3 years 5 months . was completed.
26 Sep 2022
Charges

A charge with Others of Rs. 4.99 Cr registered on 26 Feb 2022 with Charge ID 100548885 was modified on 22 Apr 2022. was recorded as a recent event.
22 Apr 2022

Explore recent activity and updates - View Recent Activity